Inflammatory Bowel Disease: An Atlas of Investigation and Management
Description:
Inflammatory bowel disease (IBD) is a chronic condition in which the lining of the digestive tract becomes inflamed and covered with ulcers. There are two types of IBD: ulcerative colitis, which causes inflammation and ulcers in the lining of the rectum and colon; and Crohn's disease which causes inflammation deeper within the intestinal wall of the small intestine and can occur in other parts of the digestive system including the mouth, oesophagus, and stomach. Although both conditions are characterized by inflammation and ulceration, they are in fact different disease processes and their treatments can differ. However, the goal of IBD treatment is to eliminate inflammation and there are many types of anti-inflammatory drugs currently available. In this beautifully illustrated new book, a specialist team of three physicians and one surgeon address some of the major questions surrounding this interesting group of diseases. Key topics include: new investigative techniques; differential diagnosis and management of specific disease states; complex manifestations of IBC and in-depth presentation of new therapeutic modalities. surgeons interested in gastrointestinal disease, general physicians and for doctors and surgeons in training.
Best prices to buy, sell, or rent ISBN 9781846920134
Frequently Asked Questions about Inflammatory Bowel Disease: An Atlas of Investigation and Management
The price for the book starts from $94.39 on Amazon and is available from 3 sellers at the moment.
If you’re interested in selling back the Inflammatory Bowel Disease: An Atlas of Investigation and Management book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Inflammatory Bowel Disease: An Atlas of Investigation and Management book, the best buyback offer comes from and is $ for the book in good condition.
Not enough insights yet.
Not enough insights yet.